{"id":998161,"date":"2026-08-26T08:13:31","date_gmt":"2026-08-26T12:13:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/"},"modified":"2026-08-26T08:13:31","modified_gmt":"2026-08-26T12:13:31","slug":"tvardi-therapeutics-to-participate-in-upcoming-investor-events-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/","title":{"rendered":"Tvardi Therapeutics to Participate in Upcoming Investor Events"},"content":{"rendered":"<div class=\"mw_release\">\n<p>HOUSTON, Aug.  26, 2026  (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will participate in the following upcoming investor events:<\/p>\n<p>\n        <strong>Wells Fargo 21<\/strong><br \/>\n        <sup><br \/>\n          <strong>st<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Conference<\/strong><br \/>\n        <br \/>Format: 1-on-1 Meetings<br \/>Date: Wednesday, September 9, 2026<br \/>Location: Boston, MA<\/p>\n<p>\n        <strong>2026 Cantor Global Healthcare Conference<\/strong><br \/>\n        <br \/>Format: Fireside Chat and 1-on-1 Meetings<br \/>Date: Thursday, September 10, 2026<br \/>Time: 10:55 AM ET<br \/>Location: New York, NY<\/p>\n<p>\n        <strong>H.C. Wainwright 28<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Global Investment Conference<\/strong><br \/>\n        <br \/>Format: Company Presentation and 1-on-1 Meetings<br \/>Date: Monday, September 14, 2026<br \/>Time: 4:30 PM ET<br \/>Location: New York, NY<\/p>\n<p>The corporate presentation and H.C. Wainwright webcast will be accessible on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eU3TfeJHAcTVRw-R3NWv7BC0gpq3utstlGVAwNvhx82gS5p5dUUf7CtHKcwY02qSUbiJjldwJtPDK58MXaEKa40oNMC_5e6a_QUhO-0j4H4cPX27WGMVL5rq3Jw9tZEXePaS3ivKzxNDj_BD-wxYU5fnsQhhn6bnz44o8UA_lP5wE1g1ZjTItYPuo48_FTWR_0yLKEoujKCOAW3XCJJBIk0JhCnVnCbNSy-Tkozqv0ebmZ-tMib3ZPODNx63jJRWegnFl2OT6DjxHixQLExrawSyZjfVKmLiNNlNyrnUhomRJLqjJG4i5oyJYPGadBu13zc2vgmBRtuKeaPCU4yQjQ==\" rel=\"nofollow\" target=\"_blank\">Tvardi Investors&#8217; website<\/a>. A replay of the webcast will be available for approximately 90 days following the conference.<\/p>\n<p>\n        <strong>About Tvardi Therapeutics<\/strong>\n      <\/p>\n<p>Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases with significant unmet need. STAT3 is a central mediator across critical signaling pathways that drive immune dysregulation, inflammation and proliferation, survival and, is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. TTI-109 is an oral prodrug of TTI-101, Tvardi&#8217;s first STAT3 inhibitor, designed to deliver equivalent exposure with improved tolerability. In a completed Phase 1 healthy volunteer study, TTI-109 demonstrated pharmacodynamic STAT3 target engagement, with reductions across disease-relevant cellular and humoral immune cell populations. The Company has selected ulcerative colitis as the initial indication for TTI-109 and plans to initiate a clinical trial pending IND clearance and the availability of additional funding. Tvardi is also conducting a Phase 1b\/2 clinical trial of TTI-101 in hepatocellular carcinoma (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wz4VbbPhmvIeLbz3oITs8l2j8CjZWQ_fV0qp699LdJI2HIiVtMrqxfHLZLo1sG-GB-xg_5AM7CjTcmbxJPVYkzpqJDVvVeQaGEKHBgDg8FybO0PDrde9Kvb852rYdbRIONevCh2dhLSufsJR7haEbzbyoeErYaGhW1B0EOT4qeoOTu9FT8aQvDPWDwv6ON0Bap2S-nffQj4CMcI3vObqGWB6mnsykTMojes_6wejPbilzjAGg56AhW4rMQGE7kOE_-lHQLktK3LRwWphrR_2OE8Sl4vcS7SiVJWFdE0P3AE=\" rel=\"nofollow\" target=\"_blank\"><u>NCT05440708<\/u><\/a>). To learn more, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FpAfXz0mf42LQ2E8vSPVP5byltfflmBOmqnGYCKUBcG5gqjUBYiOoykpNiKe93ZUtymNxZ3Hbzm5osZ-Wd3Dy-VXiqSq1Xl7OtL-RR8D4qQuUZIxyj5VxNYR8aNrWRhk68dDYIew6hYE61Y42EkHr-5omoHysSjdFKSAcMBQrb45gojOCzszn305R8nJKJW8J5i_hyCQD4ViYqKkCC3VZZ3Pgvk4i_ZUnfciSlgi7FuMY7UUy1QjDi3g-2lZ6Lr44ZWoghPp7uYv4VrFMLKFZJtMKjGdIDOIkSfO2DPT--w=\" rel=\"nofollow\" target=\"_blank\"><u>tvarditherapeutics.com<\/u><\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-6be30SKeoNNAEqMi0GQfsdVKoiZ8YPp8IGJlrzvtfA2Ndbgx930chhJ-mtPGKcQPPFVj40KRj7ieakJjmr_VkTlNpMe7IsaRfZiAVuK_Vs67NYBTqEtgxaFXJ8uNE5999yXMlmd9yurg0I5lrcxL0q_ON4Ia48u-ci28knJZ9s7FUMpsqj5R5uQjcbJNOb-Wxp6E4nkMYWIW3c6wc6iahJnIvBS15D2hrkWFTzo3cNSXq7u2HbhzwyH8rkPs2lFi1n_xaXLlwgA-O4R_a_YdQ==\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Zfm43MiMxRi1uBvCHn1UE07eJUOc4v667pbPeL6FDmQ0yi0PNEVHldYxNuooNReAlqjxAXg_rlhlLtuYn5peuFsk6i_EZHB7XNT8U53p8RtU_5WhW6-IZ42rc17Cz_2jV6doQh4f0fACzgulfjBY-x0yvQv8ADWa4b0V7GnLdkawq0WzvcoKzK5_XFRA5X4a1DcSR5JqV9QlPzzR0wRbKRN8nejnb-Y0HNa7-WkCmXdfvRXv68oxw_grlztZZW_2\" rel=\"nofollow\" target=\"_blank\"><u>X (Twitter)<\/u><\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>For Tvardi:<\/strong><br \/>\n        <br \/>Tvardi Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-SKlN11vuaj8SchSsR-YRYGsgBs0Db0bUhTQarF2JplwBb-H-kjktpT0y4W42ZdJxwRjeApDCeueI9l6e0vJdg==\" rel=\"nofollow\" target=\"_blank\">ir@tvardi.com<\/a><\/p>\n<p>PJ Kelleher<br \/>LifeSci Advisors<br \/>617-430-7579<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3j3jWMJqsY6bv0TynH0PogQe3ClVGfOeh8j5Tr0bd75iJJrSuZglzB1xzdiZGjc2_fUs29jxCkNlwxA9jlQrzcU16LrpuAbJ_G8yjT_jX4wRPGPYbP49O4Xw21uJuLVP\" rel=\"nofollow\" target=\"_blank\">pkelleher@lifesciadvisors.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YjE3YTlkNTQtNmFkNi00Njg3LWIyOGItNDRkYmM0OWU1ZGQ4LTUwMDEzMjg0Mi0yMDI2LTA4LTI2LWVu\/tiny\/Tvardi-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HOUSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will participate in the following upcoming investor events: Wells Fargo 21 st Annual Healthcare Conference Format: 1-on-1 MeetingsDate: Wednesday, September 9, 2026Location: Boston, MA 2026 Cantor Global Healthcare Conference Format: Fireside Chat and 1-on-1 MeetingsDate: Thursday, September 10, 2026Time: 10:55 AM ETLocation: New York, NY H.C. Wainwright 28 th Annual Global Investment Conference Format: Company Presentation and 1-on-1 MeetingsDate: Monday, September 14, 2026Time: 4:30 PM ETLocation: New York, NY The corporate presentation and H.C. Wainwright webcast will be accessible on Tvardi &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tvardi Therapeutics to Participate in Upcoming Investor Events&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-998161","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HOUSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will participate in the following upcoming investor events: Wells Fargo 21 st Annual Healthcare Conference Format: 1-on-1 MeetingsDate: Wednesday, September 9, 2026Location: Boston, MA 2026 Cantor Global Healthcare Conference Format: Fireside Chat and 1-on-1 MeetingsDate: Thursday, September 10, 2026Time: 10:55 AM ETLocation: New York, NY H.C. Wainwright 28 th Annual Global Investment Conference Format: Company Presentation and 1-on-1 MeetingsDate: Monday, September 14, 2026Time: 4:30 PM ETLocation: New York, NY The corporate presentation and H.C. Wainwright webcast will be accessible on Tvardi &hellip; Continue reading &quot;Tvardi Therapeutics to Participate in Upcoming Investor Events&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-26T12:13:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tvardi Therapeutics to Participate in Upcoming Investor Events\",\"datePublished\":\"2026-08-26T12:13:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/\"},\"wordCount\":322,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/\",\"name\":\"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==\",\"datePublished\":\"2026-08-26T12:13:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tvardi Therapeutics to Participate in Upcoming Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/","og_locale":"en_US","og_type":"article","og_title":"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk","og_description":"HOUSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) &#8212; Tvardi Therapeutics, Inc. (\u201cTvardi\u201d) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases, today announced that management will participate in the following upcoming investor events: Wells Fargo 21 st Annual Healthcare Conference Format: 1-on-1 MeetingsDate: Wednesday, September 9, 2026Location: Boston, MA 2026 Cantor Global Healthcare Conference Format: Fireside Chat and 1-on-1 MeetingsDate: Thursday, September 10, 2026Time: 10:55 AM ETLocation: New York, NY H.C. Wainwright 28 th Annual Global Investment Conference Format: Company Presentation and 1-on-1 MeetingsDate: Monday, September 14, 2026Time: 4:30 PM ETLocation: New York, NY The corporate presentation and H.C. Wainwright webcast will be accessible on Tvardi &hellip; Continue reading \"Tvardi Therapeutics to Participate in Upcoming Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-26T12:13:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tvardi Therapeutics to Participate in Upcoming Investor Events","datePublished":"2026-08-26T12:13:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/"},"wordCount":322,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/","name":"Tvardi Therapeutics to Participate in Upcoming Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==","datePublished":"2026-08-26T12:13:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNjE5OSM3ODAzNTkwIzUwMDEzMjg0Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tvardi-therapeutics-to-participate-in-upcoming-investor-events-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tvardi Therapeutics to Participate in Upcoming Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=998161"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/998161\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=998161"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=998161"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=998161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}